G6PD deficient men have a higher risk of diabetes-related microvascular complications (odds ratio 1.37 [95% CI: 1.01, 1.86]), and are diagnosed with T2D, on average, 4.1 years later than non-carriers. This evidence concerns the gene G6PD and type 2 diabetes mellitus.